Marvel Clinical Research
Huntington Beach, California, United States
Research institute in Huntington Beach, California
17742 Beach Blvd #245, Huntington Beach, CA 92647
About Marvel Clinical Research
"Marvel Clinical Research conducts clinical research studies to help advance the world of medicine and improve lives."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Marvel Clinical Research
During the past decade, Marvel Clinical Research conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 16 clinical trials were completed, i.e. on
average, 45.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 16 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
2014-08-18
2026-10-10
Active, not recruiting
450
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
2015-07-13
2023-10-02
Active, not recruiting
300
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
2015-09-10
2033-06-30
Recruiting
600
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
2015-04-29
2031-03-29
Active, not recruiting
415
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Marvel Clinical Research" #1 sponsor was "Pfizer" with 9 trials, followed by "Incyte Corporation" with 4 trials
sponsored, "Astellas Pharma Global Development, Inc." with 2 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored and "Janssen Research & Development, LLC"
with 2 trials sponsored. Other sponsors include 11 different institutions and
companies that sponsored additional 20 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Marvel Clinical Research"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Marvel Clinical Research
According to Clinical.Site data, the most researched conditions in "Marvel Clinical Research" are
"Hot Flashes" (3 trials), "Atopic Dermatitis" (2 trials), "Dermatitis, Atopic" (2 trials), "EPP" (2 trials) and "Influenza, Human" (2 trials). Many other conditions were trialed in "Marvel Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Marvel Clinical Research
Most popular intervention types in "Marvel Clinical Research" are "Drug" (28 trials), "Biological" (7 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Vehicle" (4 trials), "placebo" (4 trials), "Ruxolitinib cream" (3 trials) and "Daridorexant 25 mg" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Marvel Clinical Research
The vast majority of trials in "Marvel Clinical Research" are
31 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Marvel Clinical Research
Currently, there are NaN active trials in "Marvel Clinical Research".
undefined are not yet recruiting,
3 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Marvel Clinical Research,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Marvel Clinical Research, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 27 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".